First AD

Second AD

Axel Merseburger, MD, PhD, is a professor of urology and chairman of the Department of Urology at University Hospital Schleswig Holstein, Campus Lübeck.

Neal Shore, MD, FACS, is the medical director for the Carolina Urologic Research Center

The expert panel concludes its discussion by providing key takeaways on the evolving bladder cancer treatment landscape following ESMO 2023.

Key Takeaways on Evolving Bladder Cancer Treatment Landscape

Genitourinary Cancers

EXE-22-OSD1273 - /clinical/genitourinary-cancer

The OncLive Genitourinary Cancer condition center page is a comprehensive resource for clinical news and expert insights across genitourinary (GU) malignancies, including renal cell carcinoma, urothelial carcinoma, and prostate cancer. This section features news articles, interviews in written and video format, and podcasts that focus on the evolving treatment paradigm of GU cancers and emerging research. 

Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

ESMO 2023: Immunotherapy Advancements in Bladder Cancer